HEPATOLOGY / EXPERIMENTAL RESEARCH
Evaluation for CpG island methylation of FASN and SREBP promoter in Mongolian gerbil NAFLD model
More details
Hide details
1
College of Animal Sciences, Zhejiang University, Zhejiang, China
2
Hangzhou Medical College, Hangzhou, China
Submission date: 2019-09-09
Final revision date: 2020-03-21
Acceptance date: 2020-04-01
Online publication date: 2021-04-05
Corresponding author
Yuehuan Liu
Hangzhou Medical College
310013, Hangzhou, China
Phone: 0086-571-88215605
Arch Med Sci 2025;21(4):1592-1601
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Methylation of the CpG island in the promoter and its nearby area is one of the most important ways to inhibit gene expression. The aim of this study was to examine the potential relationship between CpG island methylation for fatty acid synthase (FASN) and sterol regulatory element-binding protein 1 (SREBP-1).
Material and methods:
Ten newborn gerbil pups formed the NB group, 10 adult gerbils with a normal diet formed the control group, 10 adult gerbils with a high-fat diet formed the nonalcoholic fatty liver disease (NAFLD) group, and 10 8-month-old gerbils formed the aged group. Blood and liver samples were collected for serum lipid detection and histopathology. A pyrosequencing technique was employed to determine the methylation rate. Then, the transcription and expression levels for FASN and SREBP-1 were verified.
Results:
Serum cholesterol and triglyceride were significantly increased in NAFLD and aged groups (vs. control, p < 0.05). The gerbils in NAFLD and aged groups also showed obvious hepatic steatosis confirmed by histological examination. The control group had the highest methylation rates for FASN and SREBP-1, which were reduced in NAFLD and aged groups. Except for the NB group, both the transcription and expression levels of SREBP-1 and FASN genes were in the following order: control group > aged group > NAFLD group. Genes of SREBP and FASN showed a trend of hypomethylation in the NAFLD gerbil model.
Conclusions:
Expression of the SREBP gene tended to decrease, while expression of the FASN gene tended to increase with age and disease development. FASN and SREBP-1 methylation might be a new method to evaluate an NAFLD animal model and an available target for genetic marker screening.
REFERENCES (28)
1.
Lee JH, Friso S, Choi SW. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition. Nutrients 2014; 6: 3303-25.
2.
Boers R, Boers J, de Hoon B, et al. Genome-wide DNA methylation profiling using the methylation-dependent restriction enzyme LpnPI. Genome Res 2018; 28: 88-99.
3.
Fila M, Pawłowska E, Blasiak J. Mitochondria in migraine pathophysiology – does epigenetics play a role? Arch Med Sci 2019; 15: 944-56.
4.
Rozenberg JM, Shlyakhtenko A, Glass K, et al. All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. Bmc Genomics 2008; 9: 67.
5.
Christopher MA, Kyle SM, Katz DJ. Neuroepigenetic mechanisms in disease. Epigenetics Chromatin 2017; 10: 47.
6.
Zheng Y, Joyce BT, Liu L, et al. Prediction of genome-wide DNA methylation in repetitive elements. Nucleic Acids Res 2017; 45: 8697-711.
7.
de Mello VD, Matte A, Perfilyev A, et al. Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. Epigenetics 2017; 12: 287-95.
8.
Ahrens M, Ammerpohl O, von Schonfels W, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab 2013; 18: 296-302.
9.
Temmerman AM, Vonk RJ, Niezen-Koning K, Berger R, Fernandes J. Effects of dietary cholesterol in the Mongolian gerbil and the rat: a comparative study. Lab Anim 1989; 23: 30-5.
10.
Liu YH, Yu CH, Li YM. A new model: genetic characterizations of nonalcoholic fatty liver disease in Mongolian gerbil. Hepatol Int 2017; 11 (Suppl. 1): S1-1093.
11.
Shimizu K, Onishi M, Sugata E, et al. Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats. Cancer Sci 2007; 98: 1318-22.
12.
Halsted CH, Villanueva JA, Devlin AM, et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci USA 2002; 99: 10072-7.
13.
Houten SM, Argmann CA. New driver for lipid synthesis. Cell 2011; 147: 719-21.
14.
Wang LJ, Zhang HW, Zhou JY, et al. Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet. J Nutr Biochem 2014; 25: 329-36.
15.
Li D, Tian YJ, Guo J, et al. Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. Br J Nutr 2013; 110: 2156-64.
16.
Jiang MH, Fei J, Lan MS, et al. Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia 2008; 51: 1525-33.
17.
Cordero P, Campion J, Milagro FI, Martinez JA. Dietary supplementation with methyl donor groups could prevent nonalcoholic fatty liver. Hepatology 2011; 53: 2151-2.
18.
Zhou D, Hlady RA, Schafer MJ, et al. High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver. Epigenetics 2017; 12: 55-69.
19.
Fujiki K, Kano F, Shiota K, Murata M. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. Bmc Biol 2009; 7: 38.
20.
Kovalenko VM, Bagnyukova TV, Sergienko OV, et al. Epigenetic changes in the rat livers induced by pyrazinamide treatment. Toxicol Appl Pharmacol 2007; 225: 293-9.
21.
Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293: 1089-93.
22.
Ehara T, Kamei Y, Takahashi M, et al. Role of DNA methylation in the regulation of lipogenic glycerol-3-phosphate acyltransferase 1 gene expression in the mouse neonatal liver. Diabetes 2012; 61: 2442-50.
23.
Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997; 99: 838-45.
24.
Han CC, Wang JW, Pan ZX, et al. Effect of cholesterol on lipogenesis and VLDL-TG assembly and secretion in goose primary hepatocytes. Mol Cell Biochem 2013; 374: 163-72.
25.
Liu X, Li P, He C, Qu X, Guo S. Comparison of overfed Xupu and Landes geese in performance, fatty acid composition, enzymes and gene expression related to lipid metabolism. Asian-Australas J Anim Sci 2020; 33: 1957-64.
26.
Walker AK, Jacobs RL, Watts JL, et al. A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell 2011; 147: 840-52.
27.
Du X, Cai C, Yao J, Zhou Y, Yu H, Shen W. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Biochem Biophys Res Commun 2017; 483: 409-17.
28.
Shimpi PC, More VR, Paranjpe M, et al. Hepatic lipid accumulation and Nrf2 expression following perinatal and peripubertal exposure to bisphenol A in a mouse model of nonalcoholic liver disease. Environ Health Perspect 2017; 125: 87005.